Anthony J. Faugno

TL;DR: Among critically ill patients with COVID-19 in this cohort study, the risk of in-hospital mortality in this study was lower in patients treated with tocilizumab in the first 2 days of ICU admission compared with patients whose treatment did not include early use of tocilzumab, and the findings may be susceptible to unmeasured confounding.

TL;DR: A systematic review and meta-analysis was performed by as discussed by the authors to evaluate the usefulness of lactate clearance as a prognostic factor in cardiogenic shock, finding that survivors had significantly higher clearance at 6-8 hours and at 24-hour compared with nonsurvivors.

TL;DR: In this article, the authors tested the performance of crisis standards of care (CSC) guidelines for allocating scarce critical care resources during the COVID-19 pandemic and found that the algorithm incorporating comorbidities has modestly worse predictive performance for Black compared to white patients.

TL;DR: In this paper , SARS-CoV-2 aerosol dispersion from subjects with COVID-19 undergoing noninvasive respiratory support (NRS) therapy was investigated. But, the results demonstrated that NRS therapies do not result in increased dispersal of aerosols in the clinical setting.

TL;DR: In this paper , the authors compared clinical characteristics, hospital trajectory, and drug and device use between patients with ST-segment elevation myocardial infarction-related cardiogenic shock (STEMI-CS) and those without (non-stent elevation mycardial infarrction complicated by cardiogenesis shock [NSTEMI]-CS), and found that despite increasing use of inotropic and vasoactive support and mechanical circulatory support throughout the hospitalization, both patients with STEMI -CS and NSTEM-CS remain at increased risk for in-hospital mortality.